São Paulo - Delayed Quote BRL

Afya Limited (A2FY34.SA)

43.51 -1.58 (-3.50%)
At close: May 31 at 8:46 PM GMT-3
Loading Chart for A2FY34.SA
DELL
  • Previous Close 45.09
  • Open 48.98
  • Bid 38.01 x --
  • Ask 44.04 x --
  • Day's Range 43.51 - 48.98
  • 52 Week Range 35.20 - 58.50
  • Volume 17
  • Avg. Volume 122
  • Market Cap (intraday) 7.631B
  • Beta (5Y Monthly) 0.98
  • PE Ratio (TTM) 8.29
  • EPS (TTM) 5.25
  • Earnings Date Aug 26, 2024 - Aug 30, 2024
  • Forward Dividend & Yield --
  • Ex-Dividend Date --
  • 1y Target Est --

Afya Limited operates as a medical education group in Brazil. The company operates through three segments: Undergrad, Continuing Education, and Digital Services. It offers educational products and services, including medical schools, medical residency preparatory courses, graduate courses, and other programs to lifelong medical learners enrolled across its distribution network, as well as to third-party medical schools. The company provides digital health services, such as subscription-based mobile app and website portal that focuses on assisting health professionals and students with clinical decision-making through tools, such as medical calculators, charts, and updated content, as well as prescriptions, clinical scores, medical procedures and laboratory exams, and others. It offers health sciences courses, which comprise medicine, dentistry, nursing, radiology, psychology, pharmacy, physical education, physiotherapy, nutrition, and biomedicine; and degree programs and courses in other subjects and disciplines, including undergraduate and post graduate courses in business administration, accounting, law, civil engineering, industrial engineering, and pedagogy. In addition, the company provides medical postgraduate specialization programs; printed and digital content; and an online medical education platform and practical medical training services. Further, it offers iClinic, a practice management software; educational health and medical imaging solutions through an interactive platform; Cliquefarma, a free-to-use website that tracks prescription drugs, cosmetics and personal hygiene product prices; Shosp, a clinical management software; RX PRO, a solution that connects physicians with the pharmaceutical industry; and Glic, a free diabetes care and management app solution for physicians and patients. The company was founded in 1999 and is headquartered in Nova Lima, Brazil.

www.afya.com.br

--

Full Time Employees

December 31

Fiscal Year Ends

Recent News: A2FY34.SA

Performance Overview: A2FY34.SA

Trailing total returns as of 5/31/2024, which may include dividends or other distributions. Benchmark is

.

YTD Return

A2FY34.SA
18.06%
S&P 500
10.64%

1-Year Return

A2FY34.SA
17.59%
S&P 500
15.87%

3-Year Return

A2FY34.SA
17.59%
S&P 500
15.87%

5-Year Return

A2FY34.SA
17.59%
S&P 500
15.87%

Compare To: A2FY34.SA

Select to analyze similar companies using key performance metrics; select up to 4 stocks.

Statistics: A2FY34.SA

Valuation Measures

Annual
As of 5/31/2024
  • Market Cap

    7.63B

  • Enterprise Value

    9.71B

  • Trailing P/E

    8.29

  • Forward P/E

    --

  • PEG Ratio (5yr expected)

    --

  • Price/Sales (ttm)

    1.35

  • Price/Book (mrq)

    1.00

  • Enterprise Value/Revenue

    3.27

  • Enterprise Value/EBITDA

    8.25

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    16.08%

  • Return on Assets (ttm)

    6.77%

  • Return on Equity (ttm)

    13.73%

  • Revenue (ttm)

    2.97B

  • Net Income Avi to Common (ttm)

    477.59M

  • Diluted EPS (ttm)

    5.25

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    611.08M

  • Total Debt/Equity (mrq)

    69.63%

  • Levered Free Cash Flow (ttm)

    142.17M

Research Analysis: A2FY34.SA

Company Insights: A2FY34.SA

Research Reports: A2FY34.SA